Yeda and Deerfield Create Orchard Innovations (Hebrew PR)

Deerfield Commits up to $130 million to Advance New Medicines at Israeli Institute Through a Newly Launched Company

Yeda, the Commercial Arm of the Weizmann Institute of Science, and Deerfield Create Orchard Innovations, LLC

Deerfield Commits up to $130 million to Advance New Medicines at the Israeli Institute Through a Newly Launched Company

The prestigious Leiden ranking puts the impact of Institute research high up in a list of the top universities and research institutes 08.07.2018

The Weizmann Institute of Science has been placed ninth in a ranking of research quality.  This is the second time that the Institute has ranked in the top ten best research institutes in the world. (In the previous ranking, in 2015, the institute placed tenth.) The placement comes from the annual CWTS Leiden Ranking, based in Leiden University in the Netherlands.

Tel Aviv --   February 1,  2016:   NewCO2Fuels  (NCF), an Israeli start-up which transforms CO2 emissions into a clean fuel that can be sold as a commodity at competitive prices, was anno unced as the winner of the "Innovation Potential" category during the 2015 International Quality Inno vation of the Year Awards Ceremony this month in Tallinn, Estonia.

Naiberg to head technology transfer at UCLA

Originally printed as an advertisement feature in Nature, Vol. 533, No. 7601 (5 May 2016)

One cannot predict what scientific discoveries or revolutions will be made in the laboratories of the Weizmann Institute of Science; but whatever they are, Yeda Research
and Development Co. will be there to bring them to market.

EAU TV spoke to Mark Emberton, UCL, and Eva Johannsen, University of Gothenburg at EAU16 about the use and limitations of active surveillance, how it affects quality of life, and a new drug that facilitates better prostate treatment.

Weizmann Institute Drug, TOOKAD® Soluble, Approved for Prostate Cancer Therapy in Mexico

A therapy invented at the Weizmann Institute of Science and clinically developed in collaboration with Steba Biotech (Luxembourg) has been approved by Cofepris, Mexico’s health authority, for the focal treatment of early-stage prostate cancer.

NCF’s technology, which captures CO2 emissions and turns them into fuel, may offer an alternative to cutting back on greenhouse gases

DAPHNE ROUSSEAU. 2015

The company called NewCO2Fuels, or NCF, has been developing its own version of a technology that allows heat-trapping carbon dioxide emissions to be captured and recycled back into useable fuel.

It sounds complicated — and it is — but the company’s founders say it holds real potential in the fight against global warming.